Published online Jul 21, 2024. doi: 10.3748/wjg.v30.i27.3268
Revised: June 5, 2024
Accepted: June 28, 2024
Published online: July 21, 2024
Processing time: 117 Days and 15.9 Hours
In this editorial, we comment on the article by Stafie et al. Inflammatory bowel disease (IBD) constitutes a cluster of chronic and progressive inflammatory disorders affecting the digestive system. IBD can impede an individual’s capacity to perform daily activities, hinder work productivity, limit physical capabilities, and negatively impact medical outcomes. Although physical activity and structured exercise programs are becoming increasingly important in many chronic inflammatory diseases, they are not being sufficiently implemented in IBD patients. Effective prevention of future disability and drug dependence in IBD patients requires timely diagnosis and treatment of musculoskeletal problems, including sarcopenia, as well as decreased muscle strength, aerobic capacity, and bone mineral density. To improve treatment outcomes for IBD patients, it is crucial to develop individualized rehabilitation programs tailored to their unique needs. Equally critical is the active participation of pertinent departments in this process. It is imperative to highlight the significance of creating a personalized rehabilitation program with a multidisciplinary approach in IBD management.
Core Tip: Effectively managing clinical issues in inflammatory bowel disease (IBD) patients is critical to reducing the risk of long-term disability and facilitating optimal health outcomes. This includes addressing concerns such as decreased bone mineral density, muscle weakness, limited aerobic capacity, and sarcopenia. Customized structured exercise programs should be provided for patients in accordance with their individual needs, considering factors such as joint involvement, frailty, fatigue, and disease activity. Healthcare providers should adopt a multidisciplinary approach to provide personalized exercise recommendations, educate patients, and address misconceptions. This approach improves quality of life, minimizes complications associated with IBD, and enhances treatment success.
- Citation: Ata BN, Eyigor S. What aspects do we overlook in the rehabilitation of patients with inflammatory bowel disease? World J Gastroenterol 2024; 30(27): 3268-3272
- URL: https://www.wjgnet.com/1007-9327/full/v30/i27/3268.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i27.3268
Inflammatory bowel disease (IBD) is an umbrella term that encompasses two disease entities, Crohn’s disease and ulcerative colitis, which are chronic, progressive inflammatory disorders of the digestive system. This disease imposes a significant burden on healthcare systems, leading to substantial annual healthcare expenditures. IBD is a condition that can lead to a variety of primary and secondary symptoms that can include diarrhea, abdominal pain, urgency, fatigue, frailty, anorexia, and depression[1]. Secondary symptoms significantly impact an individual’s daily routine, work productivity, academic performance, physical abilities, medical outcomes, and overall quality of life (QOL). Young patients with IBD are seldom advised to engage in physical activity, which can result in a sedentary lifestyle due to concerns regarding potential complications[2].
It is crucial to distinguish between the terms “structured exercise” and “physical activity” because they are frequently used interchangeably. Structured exercise and physical activity are two distinct types of activities that exhibit physio
Currently, there is a lack of a comprehensive guide for healthcare practitioners or a detailed evidence-based physical rehabilitation protocol for IBD[7]. It is recommended that IBD patients engage in structured exercise under medical supervision until such time that they are deemed capable of doing so independently[8]. Inpatient rehabilitation programs can improve the physical mobility of IBD patients after they reach a state of medical stability[9]. When oxygen capacity is impaired due to anemia or dehydration, structured exercise and physical rehabilitation programs should be planned to include elements such as tempo, workload distribution, and rest intervals[10]. Employing suitable rehabilitation strategies and structured exercises can mitigate complications, such as gastrointestinal bleeding, that may develop due to excessive exercise[4]. There is evidence that shows aerobic exercise regimens can provide cardiovascular and psychosocial benefits for adult IBD patients with mild to moderate disease who are in clinical remission[11].
Despite exhibiting body compositions that are comparable to those of healthy controls, IBD patients in remission exhibit reduced muscle strength and power[12]. This may be due to impaired nutrient absorption, weight loss, decreased physical activity, and the upregulation of cytokines, which leads to muscle atrophy. Reduced muscle strength and function lead to functional deficits. Resistance exercise, when prescribed appropriately, aids muscle growth and strength by stimulating the release of biologically active myokines[13]. Populations with a higher risk of sarcopenia, malnutrition, being female, or being older have higher rates of complications. The early assessment of lower extremity and core strength can play a vital role in identifying individuals with IBD who are at risk of preclinical disability. Thus, timely diagnosis and treatment of musculoskeletal problems in these patients can effectively prevent future dependence and disability[14].
Both aerobic and resistance exercise training have been scientifically validated as effective approaches for improving cardiovascular health as well as muscle mass and strength. Numerous chronic conditions, including cardiovascular disease, diabetes, and rheumatoid arthritis, are believed to be impacted by insufficient physical activity. Interleukins (IL), leukocytes, tumor necrosis factor, and visceral fat play a significant role in the pathogenesis and progression of IBD[15]. The potential benefits of exercise for individuals with IBD are linked to its anti-inflammatory properties. Physical activity is recognized for its ability to reduce inflammation by releasing anti-inflammatory myokines, such as IL-6, into the circulation in large quantities during exercise[16]. Furthermore, exercise may contribute to positive outcomes by reducing adipose tissue in the abdominal and intestinal regions[17]. Patients with IBD have concerns about engaging in physical exercise, unlike healthy individuals. While several studies have demonstrated the safety and effectiveness of physical activity in IBD patients, these studies primarily included patients with mild disease or those in remission[18].
The most common extra-intestinal symptom in IBD patients is articular involvement, with a prevalence of 17%-39%[19]. Although it is often characterized by involvement of axial joints, it may also be associated with peripheral arthritis such as synovitis and/or dactylitis and/or enthesopathy. IBD-related arthritis rehabilitation aims to prevent disability and deformity. Physical therapy is crucial for enhancing spinal mobility to prevent spinal deformities that could impair breathing and cause disability.
Patients with IBD have a higher risk of fractures compared to the general population. Adequate nutrition and a combination of progressive low-impact and resistance exercise training are important for preventing and treating osteoporosis[3].
IBD patients exhibit alterations in body composition due to the catabolic state caused by chronic inflammation and the use of treatments such as corticosteroids. Therefore, IBD patients frequently develop sarcopenia. The prevalence of sarcopenia is reported to be 52% and 37% in Crohn’s disease and ulcerative colitis, respectively. However, accurately determining the precise prevalence is challenging[20]. Sarcopenia exerts a significant impact on QOL, duration of hospitalization, surgical outcomes, and mortality. This is an important consideration in the management of IBD, as it impacts both prognosis and treatment. Although sarcopenia is defined as age-related loss of muscle mass, it is known that it can also occur as a result of chronic illness, inactivity, and inflammation[21]. Research suggests that patients with sarcopenia may benefit from personalized resistance and aerobic exercise regimens[22].
Prehabilitation is a multimodal (nutritional, exercise, and psychological) intervention that aims to increase functional ability in the presence of impending physical stress (e.g., surgery). While most studies have concentrated on cancer patients, this strategy could have a significant impact on IBD patients with refractory disease awaiting elective surgery[23].
The epidemiology of IBD varies significantly across different regions of the globe. Although IBD is more prevalent in Western societies, which are characterized by higher socioeconomic status and improved health conditions, there has been a significant rise in the incidence and prevalence of IBD in developing countries like Türkiye[24].
In developed countries, the average rate of non-adherence to treatment is 50%, and in developing countries, this figure is even higher. Furthermore, IBD has been associated with an increase in disease activity, relapse, diminished response to medical agents, higher morbidity and mortality, and increased health expenditure[25]. To address these concerns, tele-health services may be employed, which are both feasible and acceptable in terms of patient education, evaluation of treatment compliance, and emphasizing the need for personalized rehabilitation programs. More comprehensive research is necessary to utilize these systems for improving healthcare access in developing nations[26].
In IBD patients, several factors such as reduced bone mineral density, diminished muscle strength, decreased aerobic capacity, and sarcopenia are often not adequately screened or treated during medical evaluation. A multidisciplinary approach helps address the comorbidities accompanying IBD and reduces subsequent morbidity and mortality. Furthermore, personalized rehabilitation programs can help alleviate the economic burden and frequency of disease exacerbations that are associated with the condition. Therefore, it is imperative that healthcare professionals prioritize these factors and ensure that they are addressed appropriately to improve the overall health outcomes of patients. To obtain optimal results, it is essential to collaborate with a team of specialized professionals, including a gastroenterologist, surgeon, rheumatologist, and physiatrist. This editorial aims to underline the significance of developing a specific rehabilitation program for IBD patients and assessing them from a comprehensive perspective. This is crucial in mitigating morbidity and mortality along with tackling the issue of physical inactivity among IBD patients, as was highlighted in the main article by Stafie et al[27].
1. | Bilski J, Mazur-Bialy AI, Wierdak M, Brzozowski T. The impact of physical activity and nutrition on inflammatory bowel disease: the potential role of cross talk between adipose tissue and skeletal muscle. J Physiol Pharmacol. 2013;64:143-155. [PubMed] [Cited in This Article: ] |
2. | Bondurri A, Maffioli A, Danelli P. Pelvic floor dysfunction in inflammatory bowel disease. Minerva Gastroenterol Dietol. 2015;61:249-259. [PubMed] [Cited in This Article: ] |
3. | Elia J, Kane S. Adult Inflammatory Bowel Disease, Physical Rehabilitation, and Structured Exercise. Inflamm Bowel Dis. 2018;24:2543-2549. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis (0)] |
4. | Narula N, Fedorak RN. Exercise and inflammatory bowel disease. Can J Gastroenterol. 2008;22:497-504. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 3.6] [Reference Citation Analysis (0)] |
5. | Gravina AG, Pellegrino R, Durante T, Palladino G, D'Onofrio R, Mammone S, Arboretto G, Auletta S, Imperio G, Ventura A, Romeo M, Federico A. Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The "BE-FIT-IBD" study. World J Gastroenterol. 2023;29:5668-5682. [PubMed] [DOI] [Cited in This Article: ] [Cited by in F6Publishing: 3] [Reference Citation Analysis (1)] |
6. | Geraci A, Tomasello G, Sabetta SP. Orthopaedic experience on inflammatory bowel disease (Lesniowski-Crohn's disease and ulcerative colitis). Ortop Traumatol Rehabil. 2010;12:430-434. [PubMed] [Cited in This Article: ] |
7. | Manabe I. Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ J. 2011;75:2739-2748. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 151] [Cited by in F6Publishing: 159] [Article Influence: 12.2] [Reference Citation Analysis (0)] |
8. | Nathan I, Norton C, Czuber-Dochan W, Forbes A. Exercise in individuals with inflammatory bowel disease. Gastroenterol Nurs. 2013;36:437-442. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis (0)] |
9. | Delaney CP, Zutshi M, Senagore AJ, Remzi FH, Hammel J, Fazio VW. Prospective, randomized, controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum. 2003;46:851-859. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 375] [Cited by in F6Publishing: 384] [Article Influence: 18.3] [Reference Citation Analysis (0)] |
10. | Dean E. Oxygen transport deficits in systemic disease and implications for physical therapy. Phys Ther. 1997;77:187-202. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
11. | Elsenbruch S, Langhorst J, Popkirowa K, Müller T, Luedtke R, Franken U, Paul A, Spahn G, Michalsen A, Janssen OE, Schedlowski M, Dobos GJ. Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom. 2005;74:277-287. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 115] [Cited by in F6Publishing: 112] [Article Influence: 5.9] [Reference Citation Analysis (0)] |
12. | Geerling BJ, Badart-Smook A, Stockbrügger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr. 1998;67:919-926. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 185] [Cited by in F6Publishing: 184] [Article Influence: 7.1] [Reference Citation Analysis (0)] |
13. | Costamagna D, Costelli P, Sampaolesi M, Penna F. Role of Inflammation in Muscle Homeostasis and Myogenesis. Mediators Inflamm. 2015;2015:805172. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 144] [Cited by in F6Publishing: 180] [Article Influence: 20.0] [Reference Citation Analysis (0)] |
14. | Ward LM, Ma J, Rauch F, Benchimol EI, Hay J, Leonard MB, Matzinger MA, Shenouda N, Lentle B, Cosgrove H, Scharke M, Konji VN, Mack DR. Musculoskeletal health in newly diagnosed children with Crohn's disease. Osteoporos Int. 2017;28:3169-3177. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis (0)] |
15. | van Langenberg DR, Della Gatta P, Hill B, Zacharewicz E, Gibson PR, Russell AP. Delving into disability in Crohn's disease: dysregulation of molecular pathways may explain skeletal muscle loss in Crohn's disease. J Crohns Colitis. 2014;8:626-634. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis (0)] |
16. | Das DK, Graham ZA, Cardozo CP. Myokines in skeletal muscle physiology and metabolism: Recent advances and future perspectives. Acta Physiol (Oxf). 2020;228:e13367. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 40] [Cited by in F6Publishing: 71] [Article Influence: 17.8] [Reference Citation Analysis (0)] |
17. | Bilski J, Mazur-Bialy A, Brzozowski B, Magierowski M, Zahradnik-Bilska J, Wójcik D, Magierowska K, Kwiecien S, Mach T, Brzozowski T. Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence. Pharmacol Rep. 2016;68:827-836. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis (0)] |
18. | Klare P, Nigg J, Nold J, Haller B, Krug AB, Mair S, Thoeringer CK, Christle JW, Schmid RM, Halle M, Huber W. The impact of a ten-week physical exercise program on health-related quality of life in patients with inflammatory bowel disease: a prospective randomized controlled trial. Digestion. 2015;91:239-247. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 7.8] [Reference Citation Analysis (0)] |
19. | Peluso R, Manguso F, Vitiello M, Iervolino S, Di Minno MN. Management of arthropathy in inflammatory bowel diseases. Ther Adv Chronic Dis. 2015;6:65-77. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis (0)] |
20. | Dhaliwal A, Quinlan JI, Overthrow K, Greig C, Lord JM, Armstrong MJ, Cooper SC. Sarcopenia in Inflammatory Bowel Disease: A Narrative Overview. Nutrients. 2021;13. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 12] [Cited by in F6Publishing: 50] [Article Influence: 16.7] [Reference Citation Analysis (0)] |
21. | Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:601. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 599] [Cited by in F6Publishing: 1167] [Article Influence: 233.4] [Reference Citation Analysis (0)] |
22. | Gold SL, Raman M, Sands BE, Ungaro R, Sabino J. Review article: Putting some muscle into sarcopenia-the pathogenesis, assessment and clinical impact of muscle loss in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2023;57:1216-1230. [PubMed] [DOI] [Cited in This Article: ] [Cited by in F6Publishing: 11] [Reference Citation Analysis (0)] |
23. | Bak MTJ, Ruiterkamp MFE, van Ruler O, Campmans-Kuijpers MJE, Bongers BC, van Meeteren NLU, van der Woude CJ, Stassen LPS, de Vries AC. Prehabilitation prior to intestinal resection in Crohn's disease patients: An opinion review. World J Gastroenterol. 2022;28:2403-2416. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (4)] |
24. | Can G, Poşul E, Yılmaz B, Can H, Korkmaz U, Ermiş F, Kurt M, Dağlı Ü. Epidemiologic features of ınflammatory bowel disease in Western Blacksea region of Turkey for the last 10 years: retrospective cohort study. Korean J Intern Med. 2019;34:519-529. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis (0)] |
25. | Chan W, Chen A, Tiao D, Selinger C, Leong R. Medication adherence in inflammatory bowel disease. Intest Res. 2017;15:434-445. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 69] [Cited by in F6Publishing: 99] [Article Influence: 14.1] [Reference Citation Analysis (0)] |
26. | Hommel KA, Hente E, Herzer M, Ingerski LM, Denson LA. Telehealth behavioral treatment for medication nonadherence: a pilot and feasibility study. Eur J Gastroenterol Hepatol. 2013;25:469-473. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 78] [Cited by in F6Publishing: 86] [Article Influence: 7.8] [Reference Citation Analysis (0)] |
27. | Stafie R, Singeap AM, Rotaru A, Stanciu C, Trifan A. Bridging the gap: Unveiling the crisis of physical inactivity in inflammatory bowel diseases. World J Gastroenterol. 2024;30:1261-1265. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (1)] |